Complication of rapidly progressive glomerulonephritis in severe congenital neutropenia treated with long-term granulocyte colony-stimulating factor (filgrastim) [2]

British Journal of Haematology

Volumn 110, Issue 1, 2000, Pages 234-235

  Sotomatsu, M ^a   Kanazawa, T ^a   Ogawa, C ^a   Watanabe, T ^a   Monikawa, A ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Crescent; Granulocyte colony stimulating factor; Kostmann's syndrome; Rapidly progressive glomerulonephritis; Severe congenital neutropenia

Indexed keywords

CEFDINIR; CEFDITOREN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; METHYLPREDNISOLONE; MINOCYCLINE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; WARFARIN;

ANTIBIOTIC PROPHYLAXIS; CASE REPORT; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOTHERAPY; INFANT; INFECTION RISK; KOSTMANN SYNDROME; LETTER; LEUKOCYTE COUNT; MALE; NEUTROPENIA; ONSET AGE; OSTEOPENIA; PRIORITY JOURNAL; QUALITY OF LIFE; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS;

EID: 0033869937     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02072-1.x     Document Type: Letter

References (6)

1. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (R-metHuG-CSF) in patients with severe congenital neutropenias
2. Neutrophil activation and hemopoietic changes in healthy donors receiving granulocyte colony-stimulating factor
3. Bone mineralization and turnover in children with congenital neutropenia, and its relationship to treatment with recombinant human granulocyte-colony stimulating factor
4. Infantile genetic agranulocytosis
5. Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia
6. Severe chronic neutropenia: Pathophysiology and therapy